Innovation

Offering recent UK migrants tests for tuberculosis in primary care

A Southampton TB specialist nurse worked with local GP practices to offer recent migrants to the UK testing for tuberculosis in primary care. This initiative won the Infection Prevention and Control category in the 2018 Nursing Times Awards

Abstract

Incidence of tuberculosis (TB) is declining but is still a significant health problem. Evidence shows that 71% of active cases in the UK occur in patients born abroad and may be the result of activated latent infection acquired in their birth country. NHS England and Public Health England have funded a new national screening programme to offer TB tests in primary care to recent migrants to the UK. The programme commenced in pilot areas with high rates of the disease, including Southampton, where a TB specialist nurse has implemented screening in partnership with 11 Southampton GP surgeries. Among those tested, the programme had a 15% rate of positive results – this demonstrates the value of targeted screening.

Citation: Fudge D (2019) Offering recent UK migrants tests for tuberculosis in primary care. Nursing Times [online]; 115: 9, 41-42.

Author: Deborah Fudge is TB Specialist nurse, TB Screening and BCG Vaccination Centre, Royal South Hants Hospital, Solent NHS Trust.

  • Scroll down to read the article or download a print-friendly PDF here (if the PDF fails to fully download please try again using a different browser)
  • To contact Deborah Fudge about this project, please email: deborah.fudge@nhs.net
  • To find out more about the NT Awards click here
  • Award category sponsored by Gojo

Introduction

Although incidence of tuberculosis (TB) in the UK is declining, it is still a significant health problem. Incidence in England is higher than in most other countries in Western Europe, and is largely focused in a number of high-incidence areas. The vast majority of active cases of TB (71%) occur in patients who were born overseas – mainly in countries with a high incidence of the disease – and may be the result of activated latent infection that was acquired in their birth country (Public Health England, 2018; NHS England and PHE, 2015).

Together, NHS England and Public Health England have funded a new national screening programme to offer TB tests in primary care services to eligible patients who are new migrants to the UK; this was implemented in areas of the UK with high TB rates. After Southampton was identified as a ‘hot spot’ and awarded funding, a Southampton TB nurse specialist implemented screening for latent infection in 11 GP practices.

Benefits of testing for latent TB

Active TB can cause great physical, emotional and social harm. Patients can become very unwell and may need to be hospitalised for long periods; without treatment the illness can be fatal. Patients with active pulmonary TB also represent a risk of onward transmission.

Treatment involves taking daily medication for many months – in the initial stage this can involve taking more than 10 tablets a day and patients may experience unpleasant or dangerous side-effects from the treatment.

Individuals with latent infection experience no symptoms and are likely to be unaware they have an infection. However, they are at increased risk of developing active disease as 5-10% of latent infections progress to become active (O’Garra et al, 2013). As such, identifying and treating latent TB can prevent future active cases and potential transmission of infection. According to NHSE and PHE (2015), screening for new entrants to the UK who come from countries with a high incidence of TB is an effective public health intervention. Box 1 lists patient eligibility criteria for screening.

Box 1. Patient eligibility criteria

For inclusion in the screening programme patients must:

  • Be 16-35 years old
  • Have been born or have lived for six months or more in a country identified as high risk – that is, a country where the rate of TB is >150 per 100,000
  • Have moved to the UK in the past five years
  • Not had a TB blood test in the UK or been diagnosed/treated for TB before

In Southampton we extended screening to all asylum seekers and patients who arrived in the UK more than five years ago but have travelled to a high-risk area in the last five years.

Although it requires an initial investment, the prevention of active cases will yield budget savings after about four years. In the US, a focus on detecting latent disease in new migrants was instrumental in reducing the number of active TB cases by 55% between 1993 and 2010 (Ormerod, 2013).

Aims

Our initiative aimed to increase TB awareness among the professionals working in the 11 GP surgeries and patients eligible for screening, break down misconceptions and stigma related to the disease, and make the TB test available and easy to access for these patients. We hoped this would enable us to identify latent TB infections and refer patients testing positive to our specialist TB service, where they could be offered treatment and support. Finally, we also aimed to speed up the diagnosis of active TB by offering testing and raising awareness of symptoms for when patients present to a GP surgery feeling unwell.

All GP practices in Southampton were informed about a proposed primary care screening programme and invited to participate.

Implementation

Funding for a role partly dedicated to implementing a screening programme in primary care was granted from July 2016; I was appointed to the role and approached the 11 GP practices that had expressed an interest in participating.

I undertook testing in the first practice to participate, as it did not have an available member of staff to take bloods at that time. I searched through hundreds of patient records to identify those eligible for screening, sent out invitation letters, telephoned and booked patient appointments, and then performed their test. The practice employed a new healthcare assistant (HCA) in this period so, once the service was up and running, the HCA and a practice nurse were able to undertake testing.

I worked with each surgery to identify and invite patients, and also trained their HCAs and nurses in how to perform the test, organise the weekly courier service to take samples for laboratory testing, and respond to results when received.

We experienced a number of challenges, in particular with the laboratory provision. The cost of sending samples to the out-of-area provider that was used at the time meant we were restricted to two collections per week. We have since moved to a local provider; this means surgeries can send samples every day via their regular courier with reduced administration. The new laboratory also provides results in a more secure electronic format than the emailed results that were provided by the previous laboratory.

Implementing change always involves challenges; it can take perseverance to continue without being discouraged.

Results

Screening started in August 2016 and, at the time of publication (two years and 10 months later), we have provided tests to 1,659 patients; 244 (15%) of these have tested positive for active or latent TB. This demonstrates the value of offering targeted screening. Many of the patients with latent infection have attended the TB clinic for treatment.

Future plans

Ideally, all Southampton GP practices should be offering TB screening to their eligible patients to avoid inequities in provision. We are, therefore, in the process of recruiting more surgeries. We attended a recent training event for GPs, practice nurses and HCAs with our consultants to generate interest and I am currently visiting individual surgeries to give talks and help them set up the service. I have also attended local community events to raise awareness.

In other areas, TB specialist nurses prescribe treatment to patients with latent TB and we are planning to implement this in Southampton. This will reduce clinic waiting times and the pressure on our consultants. More importantly, it will be better for patients as it will reduce the delay in starting treatment.

We will continue to raise TB awareness both with primary care staff and with patients. The ultimate goal of this national screening programme is to eradicate TB; by treating latent cases, we can reduce patient morbidity by preventing active disease, as well as preventing infection spread by reducing the number of active cases. For a more detailed report of this initiative see Fudge (2018).

Key points

  • Incidence of tuberculosis in the UK is higher than in many countries in Western Europe
  • Most cases of active disease occur in people who were born outside of  the UK
  • Testing recent migrants from high-incidence countries can identify cases of latent infection
  • Treating latent infection prevents morbidity associated with active disease and prevents onward transmission

References


Fudge D (2018) A primary care screening model to identify latent tuberculosis infection. Nursing Times; 114: 5, 48-50.

NHS England and Public Health England (2015) Collaborative Tuberculosis Strategy for England: 2015-2020.

O’Garra A et al (2013) The immune response in tuberculosis. Annual Review of Immunology; 31: 475-527.

Ormerod L (2013) Further evidence supporting programmatic screening for, and treatment of latent TB Infection (LTBI) in new entrants to the UK from high TB prevalence countries. Thorax; 68: 3, 201.

Public Health England (2018) Tuberculosis in England: 2018 – Presenting Data to End of 2017.

 

Related files

Have your say

or a new account to join the discussion.

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.
  翻译: